OZONATE™ LSR Capsules

Description

OZONATE-LSR combines Pantoprazole with Levosulpiride, offering dual action by reducing gastric acid secretion and improving gastrointestinal motility. It is especially effective in acid reflux disorders associated with functional dyspepsia.

Composition

Each capsule contains:

• Pantoprazole (Enteric Coated) …… 40 mg
• Levosulpiride (Sustained Release) …… 75 mg
• Excipients …… q.s.

Dosage & Administration

• Adults: One capsule once daily, before meals, or as directed by the physician.

Indications

• Gastroesophageal reflux disease (GERD)
• Functional dyspepsia
• Gastric and duodenal ulcers
• Hyperacidity
• Zollinger–Ellison syndrome
• Burning mouth syndrome

Contra-Indications

• Hypersensitivity to Levosulpiride or Pantoprazole
• Epilepsy
• Prolactin-dependent tumors

Precautions

• Use with caution in elderly patients
• Long-term use should be monitored
• May cause dizziness or somnolence

Storage

• Store in a cool, dry place
• Keep away from direct sunlight

Common Disclaimer (All Products)

To be sold by retail on the prescription of a registered medical practitioner only.